Medicine/Healing

Two movements converge in Mexico at cryptopsychedelic

*Age-standardised disability-adjusted life year (DALY) rates from Post-traumatic stress disorder by country (per 100,000 inhabitants).​ “We can do legalization and decriminalization, but we need a reparative component to these policies” … Betty Aldworth, the Executive Director of Students for Sensible Drug Policy continued with a plea for more compassion in different drug use contexts. “I…

READ MORE
Medicine/Healing

First weed, now mushrooms

Just in my short lifetime, I’ve seen marijuana rebranded from a super illegal, black market, highly stigmatized substance to one of the most celebrated alternative health and wellness treatments out there. Will legalizing magic mushrooms and other psychedelic drugs be the next big fight? The next big industry for our state? Colorado decriminalized marijuana long…

READ MORE
Medicine/Healing

Drug testing of employees is beginning to slow

More than one in five American adults can eat, drink, smoke or vape [cannabis] as they please. The result is the slow decline of pre-employment drug tests, which for decades had been a requirement for new recruits in industries ranging from manufacturing to finance. As of the beginning of 2018, Excellence Health Inc., a Las…

READ MORE
Medicine/Healing

Denver may get to vote on whether to make magic mushrooms legal

“There’s no reason that both shouldn’t be legalized because psilocybin or magic mushrooms are just as safe as cannabis … “We could apply lessons from cannabis legalization and apply them to psilocybin legalization,” -Neuroscientist Michele Ross The group calls itself Colorado for Psilocybin after the fungi’s scientific name. Their proposed measure would do away with…

READ MORE
Medicine/Healing

Right to try and the FDA’s proposed ban on kratom

And even if kratom can be dangerous, banning it violates the administration’s defense of Right to Try laws: potentially dangerous medicines are nevertheless valuable if their expected benefits exceed their risks. Doubts about effectiveness aside, the prima facie reasoning behind the FDA’s crackdown can be found in a press release from November 14, 2017, in…

READ MORE